EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.3.1.10 | Chronic Periodontitis |
29400320 |
Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK). |
causal interaction |
1 |
| 1.3.1.10 | Chronic Periodontitis |
29400320 |
Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK). |
therapeutic application |
1 |
| 1.3.1.10 | Chronic Periodontitis |
29400320 |
Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK). |
unassigned |
0 |
| 1.3.1.10 | Clostridium Infections |
30501172 |
The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile Infection. |
therapeutic application |
1 |
| 1.3.1.10 | Clostridium Infections |
30501172 |
The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile Infection. |
unassigned |
0 |
| 1.3.1.10 | Cysts |
14623959 |
Delivery of antimicrobials into parasites. |
ongoing research |
2 |
| 1.3.1.10 | Cysts |
14623959 |
Delivery of antimicrobials into parasites. |
unassigned |
0 |
| 1.3.1.10 | Dental Plaque |
17110966 |
Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms. |
causal interaction |
4 |
| 1.3.1.10 | Dental Plaque |
17110966 |
Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms. |
therapeutic application |
4 |
| 1.3.1.10 | Dental Plaque |
17110966 |
Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms. |
unassigned |
0 |
